涩里番

Home

Latest Alzheimer鈥檚 drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Project to create AI model for ALS receives G茅nome Qu茅bec funding

Published: 17 March 2025

$400,000 will fuel public-private collaboration to discover new disease biomarkers...

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone鈥檚 impact on brain cancer immunotherapy...

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson鈥檚, glioblastoma and dementia 听

Hughlings Jackson Lecture: New Insights into Navigation

Tuesday, March 28, 2023 16:00to17:00

Established in 1935, the Hughlings Jackson Lecture is The Neuro鈥檚 premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the...

Pages

Subscribe to Students RSS

The Neuro logo听涩里番 logo

听

The Neuro (Montreal Neurological Institute-Hospital)听is a bilingual academic healthcare institution. We are a听涩里番 research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the 涩里番 Health Centre.听We are听proud to be a Killam Institution, supported by the Killam Trusts.

听

听

Back to top